Related Experiment Video
Updated: May 31, 2026

09:07
Mouse Footpad Inoculation Model to Study Viral-Induced Neuroinflammatory Responses
Published on: June 14, 2020
Study of camelpox virus pathogenesis in athymic nude mice
Sophie Duraffour1, Patrick Matthys, Joost J van den Oord
1Rega Institute, Laboratory of Virology and Chemotherapy, K.U.L, Leuven, Belgium. sophie.duraffour@rega.kuleuven.be
Plos One
|July 9, 2011
Summary
Immunodeficient mice are susceptible to camelpox virus (CMLV) infection, unlike immunocompetent mice. This finding establishes a new animal model for studying CMLV pathogenesis and testing antiviral treatments.
Area of Science:
- Virology
- Immunology
- Infectious Diseases
Background:
- Camelpox virus (CMLV) is closely related to variola virus, the cause of smallpox.
- Recent human cases highlight the need for CMLV research, but a lack of animal models hinders pathogenesis studies.
- Previous studies indicated CMLV is restricted to camelids.
Purpose of the Study:
- To establish and characterize small animal models for CMLV infection.
- To investigate CMLV pathogenesis and immune responses in different mouse models.
- To evaluate the efficacy of antiviral treatments against CMLV.
Main Methods:
- Intranasal (i.n.) and intracutaneous (i.c.) CMLV challenges in NMRI immunocompetent and athymic nude mice.
- Monitoring of disease progression, weight changes, and CMLV replication in tissues and fluids.
- Analysis of innate immune cells (macrophages, neutrophils, NK cells) and B cell responses in spleen and lymph nodes.
- Quantification of cytokine profiles (IL-6, IL-18) in sera.
- Evaluation of antiviral efficacy using cidofovir and HPMPC.
Main Results:
- Athymic nude mice developed severe disease after i.n. CMLV infection, unlike resistant immunocompetent mice.
- CMLV replicated in tissues and fluids of both mouse models, with varying immune cell responses depending on infection route.
- HPMPC demonstrated 100% protection against CMLV-induced morbidity without affecting immune responses or cytokine levels.
Conclusions:
- Immunodeficient mice are permissive to CMLV, providing a viable model for pathogenesis research.
- This model facilitates the evaluation of antiviral therapies for CMLV in an immunodeficient context.
- HPMPC shows significant promise as an effective antiviral agent against CMLV.

